Which gene is associated with pyrrole metabolites (pyroluria)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Gene Associated with Pyrroles

The genes associated with pyrroles depend on the clinical context: for porphyrias (which involve porphyrin/pyrrole metabolism disorders), multiple genes are implicated including HMBS, ALAD, CPOX, PPOX, UROD, FECH, and ALAS2; however, if you're asking about "pyroluria" or urinary pyrroles as a proposed biomarker for anxiety/oxidative stress, no specific gene has been definitively established 1.

Context Matters: Two Different Clinical Entities

If Asking About Porphyrias (Established Medical Conditions)

The porphyrias are genetic disorders of heme biosynthesis where pyrrole-containing compounds (porphyrins and their precursors) accumulate. Each type has a specific gene:

Acute Porphyrias (presenting with neurovisceral symptoms):

  • HMBS gene - Acute Intermittent Porphyria (AIP), chromosome 11q23.3
  • ALAD gene - ALAD deficiency porphyria, chromosome 9q32
  • CPOX gene - Hereditary Coproporphyria (HCP), chromosome 3q11.2
  • PPOX gene - Variegate Porphyria (VP), chromosome 1q23.3 1

Cutaneous Porphyrias (presenting with photosensitivity):

  • UROD gene - Porphyria Cutanea Tarda (PCT), chromosome 1p34.1 (only 20% of PCT cases are familial)
  • FECH gene - Erythropoietic Protoporphyria (EPP), chromosome 18q21.31
  • ALAS2 gene - X-linked Erythropoietic Protoporphyria (XLEPP), chromosome Xp11.21 1

Critical diagnostic principle: Genetic testing should NEVER be performed without first demonstrating biochemical evidence of disease (elevated urinary PBG/ALA for acute porphyrias, or elevated porphyrins for cutaneous types). This is because these conditions have low penetrance—many people carry pathogenic variants without ever developing clinical disease 1.

If Asking About "Pyroluria" (Controversial/Unestablished)

The concept of elevated urinary pyrroles (sometimes called "kryptopyrrole" or "Mauve Factor") as a biomarker for anxiety or psychiatric disorders has been investigated for over 60 years but lacks established genetic associations or validated clinical utility 2, 3.

Recent research suggests:

  • The urinary pyrrole compounds may originate from gut microbiome metabolism of stercobilin rather than a genetic disorder 2
  • These compounds may represent oxidative stress markers from heme fragmentation by reactive oxygen species, not a specific genetic condition 3
  • Studies have not demonstrated consistent differences in pyrrole levels between anxious and non-anxious individuals using validated anxiety scales 2

Key Clinical Pitfalls

Do not confuse these two entities: Porphyrias are well-established genetic disorders with specific genes, clear diagnostic criteria, and serious clinical consequences. "Pyroluria" as a psychiatric biomarker remains scientifically unvalidated and should not guide clinical decision-making 1, 2, 3.

For suspected porphyria, always obtain biochemical confirmation (urinary PBG/ALA, porphyrins in urine/feces/blood) before genetic testing to avoid misdiagnosis and inappropriate treatment with potentially serious consequences 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.